122 related articles for article (PubMed ID: 25015994)
1. A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection.
Modlin IM; Drozdov I; Alaimo D; Callahan S; Teixiera N; Bodei L; Kidd M
Endocr Relat Cancer; 2014 Aug; 21(4):615-28. PubMed ID: 25015994
[TBL] [Abstract][Full Text] [Related]
2. Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis.
Kidd M; Drozdov IA; Matar S; Gurunlian N; Ferranti NJ; Malczewska A; Bennett P; Bodei L; Modlin IM
PLoS One; 2019; 14(6):e0218592. PubMed ID: 31247038
[TBL] [Abstract][Full Text] [Related]
3. NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis.
Malczewska A; Oberg K; Kos-Kudla B
Endocr Connect; 2021 Jan; 10(1):110-123. PubMed ID: 33289691
[TBL] [Abstract][Full Text] [Related]
4. Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors.
Pulvirenti A; Rao D; Mcintyre CA; Gonen M; Tang LH; Klimstra DS; Fleisher M; Ramanathan LV; Reidy-Lagunes D; Allen PJ
HPB (Oxford); 2019 May; 21(5):612-618. PubMed ID: 30366884
[TBL] [Abstract][Full Text] [Related]
5. The immunomodulatory functions of chromogranin A-derived peptide pancreastatin.
Ioannidis M; Mahata SK; van den Bogaart G
Peptides; 2022 Dec; 158():170893. PubMed ID: 36244579
[TBL] [Abstract][Full Text] [Related]
6. Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.
Guillemot J; Guérin M; Thouënnon E; Montéro-Hadjadje M; Leprince J; Lefebvre H; Klein M; Muresan M; Anouar Y; Yon L
PLoS One; 2014; 9(2):e88698. PubMed ID: 24523932
[TBL] [Abstract][Full Text] [Related]
7. A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management.
Oberg K; Krenning E; Sundin A; Bodei L; Kidd M; Tesselaar M; Ambrosini V; Baum RP; Kulke M; Pavel M; Cwikla J; Drozdov I; Falconi M; Fazio N; Frilling A; Jensen R; Koopmans K; Korse T; Kwekkeboom D; Maecke H; Paganelli G; Salazar R; Severi S; Strosberg J; Prasad V; Scarpa A; Grossman A; Walenkamp A; Cives M; Virgolini I; Kjaer A; Modlin IM
Endocr Connect; 2016 Sep; 5(5):174-87. PubMed ID: 27582247
[TBL] [Abstract][Full Text] [Related]
8. Established and novel circulating neuroendocrine tumor biomarkers for diagnostic, predictive and prognostic use.
Tsoli M; Koumarianou A; Angelousi A; Kaltsas G
Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101785. PubMed ID: 37336711
[TBL] [Abstract][Full Text] [Related]
9. Ten-Fold Elevation of Chromogranin A Level Unrelated to a Neuroendocrine Tumor: A Case Report of the Diagnostic Interference of Proton Pump Inhibitors.
Alkhayat MJ; Davis K; Atkins SJ; Sheikh AA; Saif MW
Cureus; 2023 Oct; 15(10):e46862. PubMed ID: 37954718
[TBL] [Abstract][Full Text] [Related]
10. Commentary to "chromogranin a: biological function and clinical utility in neuroendocrine tumor disease".
Jeske W; Glinicki P; Kapuścińska R
Ann Surg Oncol; 2011 Jan; 18(1):293. PubMed ID: 20549561
[No Abstract] [Full Text] [Related]
11. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective.
Mariën L; Islam O; Chhajlani S; Lybaert W; Peeters M; Van Camp G; Op de Beeck K; Vandamme T
Curr Treat Options Oncol; 2023 Dec; 24(12):1833-1851. PubMed ID: 37989978
[TBL] [Abstract][Full Text] [Related]
12. NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance.
van Treijen MJC; Korse CM; Verbeek WH; Tesselaar MET; Valk GD
Endocr Connect; 2022 Oct; 11(10):. PubMed ID: 35951312
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring variants of the dysglycemic peptide pancreastatin: differential potencies for multiple cellular functions and structure-function correlation.
Allu PK; Chirasani VR; Ghosh D; Mani A; Bera AK; Maji SK; Senapati S; Mullasari AS; Mahapatra NR
J Biol Chem; 2014 Feb; 289(7):4455-69. PubMed ID: 24338022
[TBL] [Abstract][Full Text] [Related]
14. An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide.
Bevere M; Masetto F; Carazzolo ME; Bettega A; Gkountakos A; Scarpa A; Simbolo M
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685358
[TBL] [Abstract][Full Text] [Related]
15. The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract.
Modlin IM; Kidd M; Bodei L; Drozdov I; Aslanian H
Am J Gastroenterol; 2015 Aug; 110(8):1223-32. PubMed ID: 26032155
[TBL] [Abstract][Full Text] [Related]
16. A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors.
Modlin IM; Aslanian H; Bodei L; Drozdov I; Kidd M
Endocr Connect; 2014 Dec; 3(4):215-23. PubMed ID: 25316294
[TBL] [Abstract][Full Text] [Related]
17. Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy.
Ćwikła JB; Bodei L; Kolasinska-Ćwikła A; Sankowski A; Modlin IM; Kidd M
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1437-45. PubMed ID: 26348352
[TBL] [Abstract][Full Text] [Related]
18. NET Blood Transcript Analysis Defines the Crossing of the Clinical Rubicon: When Stable Disease Becomes Progressive.
Pavel M; Jann H; Prasad V; Drozdov I; Modlin IM; Kidd M
Neuroendocrinology; 2017; 104(2):170-182. PubMed ID: 27078712
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine tumor biomarkers: From monoanalytes to transcripts and algorithms.
Modlin IM; Bodei L; Kidd M
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):59-77. PubMed ID: 26971844
[TBL] [Abstract][Full Text] [Related]
20. Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies.
Modlin IM; Frilling A; Salem RR; Alaimo D; Drymousis P; Wasan HS; Callahan S; Faiz O; Weng L; Teixeira N; Bodei L; Drozdov I; Kidd M
Surgery; 2016 Jan; 159(1):336-47. PubMed ID: 26456125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
